BioSpace News Archive

“Pharmaceutical and medical device industries are increasingly turning to more sustainable test methods for the accurate detection of pyrogenic contamination. In response to these market trends, we are very excited to expand our portfolio of sustainable testing solutions with the PyroCell™ MAT System, which will better support the customer’s needs during development and ensure product safety.”

Perimeter Medical Imaging AI, Inc. is providing, as required by section 11 of BC Instrument 51-517 - Temporary Exemption from Certain Corporate Finance Requirements, a 30-day update on its previously-announced 45-day extension of the filing of its interim financial statements for its second quarter ending June 30, 2020.

Arcutis Biotherapeutics, Inc. announced the pricing of its underwritten public offering of 4,000,000 shares of its common stock at a public offering price of $25.00 per share, before underwriting discounts and commissions.